Abstract:
A sound attenuation enclosure comprising a plurality of panels positioned side by side to one another and supported on a plurality of columns wherein each panel is positioned in spaced relation to an adjacent panel to allow airflow in and out of the enclosure. The panels and columns may have an enclosed inner chamber filled with a sound retardant material.
Abstract:
Devices, systems, methods, and kits for treating the tissue structures of the ear make use of a guide structure that can mechanically register a treatment probe with a target region of a target tissue, the guide structure being fittingly received in an auditory canal and often comprising a conformable body such as a compressible foam, or the like. The guide structure may include an articulating mechanism for selectively orienting the treatment probe toward the target region of, for example, a tympanic membrane. The guide structure may also support a videoscopic image capture device, illumination transmitting optical fibers, an aiming beam transmitter, and the like. Such structures facilitate myringotomy, tympanostomy tube placement, and the like, under local anesthesia in a doctor's office.
Abstract:
An igniter device comprising a holder for a piezo electric ignition source, the holder comprising a first end and a second end, wherein the first end of the inner holder is coupled to a piezo electric ignition source including an actuator, and the second end of the inner holder has a surface configured to receive a tip of an oxy fuel torch; and an attachment means to releasably attach the igniter device to a support member; wherein, the actuator is moveable from a relaxed state to a compressed state to thereby activate the piezo electric ignition source to produce a spark for igniting the oxy fuel torch to produce a flame when the igniter device is attached to the support member.
Abstract:
An embodiment of a sound attenuation enclosure comprises a body having a plurality of panels aligned side-by-side forming the enclosure wherein each panel abuts, and is positioned at an angle with respect to, an adjacent panel. The enclosure has a first opened end and a second opened end, and each panel is positioned in spaced relation to the body of the operating system within the enclosure. At least one aperture is formed in the enclosure through which a part of the operating system extends; and, at least one end cap is positioned over either the first end or second end of the enclosure wherein the end cap is separable from the body. The enclosure may have two end caps including a first end cap on the first end of the enclosure; and, a second end cap on the second end of the enclosure. The end caps are also positioned in spaced relation to the body portion of the enclosed operating system.
Abstract:
Apparatus for manipulating and securing tissue are described herein. In creating tissue folds within the body of a patient, a tissue manipulation assembly may generally have an elongate tubular member, an engagement member slidably disposed through the tubular member and a distal end adapted to engage tissue via a helical member, tissue stabilizing members positioned at the tubular member distal end which are adapted to stabilize tissue therebetween, and a delivery tube pivotable about the tissue stabilizer. The stabilizing members can be adapted to become angled relative to a longitudinal axis of the elongate tubular member. Moreover, one or all the articulation controls and functions can be integrated into a singular handle assembly connectable to the tissue manipulation assembly via a rigid or flexible tubular body.
Abstract:
Devices, systems, methods, and kits for treating the tissue structures of the ear make use of a guide structure that can mechanically register a treatment probe with a target region of a target tissue, the guide structure being fittingly received in an auditory canal and often comprising a conformable body such as a compressible foam, or the like. The guide structure may include an articulating mechanism for selectively orienting the treatment probe toward the target region of, for example, a tympanic membrane. The guide structure may also support a videoscopic image capture device, illumination transmitting optical fibers, an aiming beam transmitter, and the like. Such structures facilitate myringotomy, tympanostomy tube placement, and the like, under local anesthesia in a doctor's office.
Abstract:
A wearable container or pack that is quickly convertible into front and rear body armor without removing the pack from the torso of the wearer. The container or pack may include a bag that may be easily separated from the container or pack, and quickly dropped from the container or pack, providing supplies for another person.
Abstract:
A wearable container or pack that is quickly convertible into front and rear body armor without removing the pack from the torso of the wearer. The container or pack may include a bag that may be easily separated from the container or pack, and quickly dropped from the container or pack, providing supplies for another person.
Abstract:
Devices, systems, methods, and kits for treating the tissue structures of the ear make use of a guide structure that can mechanically register a treatment probe with a target region of a target tissue, the guide structure being fittingly received in an auditory canal and often comprising a conformable body such as a compressible foam, or the like. The guide structure may include an articulating mechanism for selectively orienting the treatment probe toward the target region of, for example, a tympanic membrane. The guide structure may also support a videoscopic image capture device, illumination transmitting optical fibers, an aiming beam transmitter, and the like. Such structures facilitate myringotomy, tympanostomy tube placement, and the like, under local anesthesia in a doctor's office.
Abstract:
The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample.